New applications on the platform enable acceleration of breakthroughs in the fight against cancer. Baltimore, MD; San Diego, CA (PRWEB) October 24, 2016 -- Proscia Inc, the industry's leading provider of cloud solutions for digital...

OptraSCANTM On-Demand Digital Pathology announced today the availability of a Breast Cancer Focused Panel of Algorithmic Biomarkers (ER/PR, HER-2/neu, Ki67, P53, EGFR, AE1/AE3) through its OptraASSAYSTM and OptraCARDSTM Solutions, as part of...

More news from Philips this week - announcing a licensing agreement with Visiopharm to combine Visiopharm's breast cancer panel with Philips' Intellisite digital pathology solution. From a scientific standpoint, as the references mentioned...

Leica Biosystems was kind enough to share with me a recent white paper on "Use of Aperio Image Analysis in Peer Reviewed Breast Cancer Research" This is a lengthy review of 30 articles published in peer-reviewed scientific journals, which...

Quantification Algorithms: Value and Progress in Standardization of IHC Breast Tissue Data April 13th, 2016 12:00 PM EST Michael Grunkin, Ph.D. Chief Executive Officer Visiopharm In collaboration with Visiopharm®, Dynamyx™ software...

Over the summer a longtime friend asked if I could review some slides for a friend of his, or actually from his friend’s wife. Of course I agreed to do so. He mentioned that she had “metastatic breast cancer” and wanted to make sure the...